Phoenix, Arizona-based RCP Diagnostics announced this morning that it has licensed its protein marker, for use in a blood diagnostic test for breast cancer. RCP said that it has licensed its protein marker to fellow Arizona firm Biomarker Technologies, which is developing a blood test for identifying cancer based on biomarkers. Financial terms were not disclosed. The licensing covers Biomarker's use of RCP's marker only for the diagnosis of breast cancer.
Top NewsThursday, May 11, 2006
RCP Diagnostics Licenses Technology